Skip to content

An exploratory clinical trial to elucidate the mechanism of glucose metabolism regulation using graduated hyperglycemic clamp method in non-diabetic subjects

An exploratory clinical trial to elucidate the mechanism of glucose metabolism regulation using graduated hyperglycemic clamp method in non-diabetic subjects - An exploratory clinical trial to elucidate the mechanism of glucose metabolism regulation using graduated hyperglycemic clamp method

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000056109
Enrollment
7
Registered
2024-11-08
Start date
2025-02-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-diabetes

Interventions

Performing a glucose clamp test on non-diabetic individuals

Sponsors

Kobe university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) not diagnosed with diabetes (2) be at least 20 years of age at the time of informed consent (3) have been fully informed of the purpose of participation in this study, and have given written consent of their own free will based on a thorough understanding of the purpose of the study

Exclusion criteria

Exclusion criteria: (1) The individuals who are taking drugs that affect glucose metabolism (steroids, immunosuppressants, beta-blockers) (2) pregnant or possibly pregnant (3) The individuals who are breast-feeding (4) The individuals have a known history of hypersensitivity to the test drug or the ingredients in the test (5) The individuals who have received a cardiac function classification of 3 or 4 by NYHA within the last 1 year (6) The individuals who have been diagnosed with severe renal dysfunction (eGFR 30 mL/min/1.73 m2 or less) within the last 1 year (7) Persons with blood clotting abnormalities (8) The individuals who have been diagnosed with thyroid function abnormalities or electrolyte within the last 1 year (9) In addition, when the principal investigator deems the patient to be inappropriate as a subject

Design outcomes

Primary

MeasureTime frame
Examination of fitting of a novel mathematical model incorporating glucose effectiveness

Secondary

MeasureTime frame
Relevance of insulin action on elevated blood glucose

Countries

Japan

Contacts

Public ContactKazuhiko Sakaguchi

Kobe university Department of Diabetes and Endocrinology

kzhkskgc@med.kobe-u.ac.jp078-382-5861

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026